Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT06792253 · RECRUITING
Trial details
- NCT number
- NCT06792253
- Sponsor
- BeBetter Med Inc
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-06
- Primary completion
- 2028-12-31
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.